Lexaria Bioscience (LEXX) Earnings Date & Reports

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LEXX is expected to report earnings to fall 14.29% to -5 cents per share on July 17

Lexaria Bioscience LEXX Stock Earnings Reports

Q2'26

Est.

$-0.06

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.07

Q3'25

Beat

by $0.02

Q2'25

Missed

by $0.05

The last earnings report on April 14 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 50.82K shares outstanding, the current market capitalization sits at 16.03M.

View a ticker or compare two or three

Compare

LEXX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LEXX